ArticleFrontiers in oral health2024

Case Report: single low-dose of denosumab as a trigger of MRONJ development in a patient with osteoporosis after bisphosphonate therapy.

Dávid Száraz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.